David Fredrickson
EVP, Oncology Business UnitAstraZeneca
PharmaceuticalsView Profile →President, Global Health and Swiss Country Affairs · Novartis
Lutz Hegemann is Novartis’s president of Global Health and Swiss Country Affairs. A physician and scientist, he has held consumer-health, operational and corporate-affairs roles while developing the company’s global-health partnerships.
Last reviewed: Nov 15, 2026
Lutz Hegemann is Novartis’s president of Global Health and Swiss Country Affairs. A physician and scientist, he has held consumer-health, operational and corporate-affairs roles while developing the company’s global-health partnerships.
Hegemann began his career as a public-health physician and scientist. In an interview published by Swiss TPH, he described treating patients with leprosy in India in the late 1980s. PATH’s appointment biography records medical and molecular-pharmacology doctoral qualifications from Utrecht.
He joined Novartis in 2005 in Consumer Health and subsequently worked across research and development, commercialization, general management and corporate affairs. He held Global Health’s chief operating officer role before becoming group head of Corporate Affairs and Global Health.
In 2022 he served briefly as interim chief strategy and growth officer while Novartis established that function. Its annual report distinguishes the temporary assignment from executive-committee membership.
His present role leads Global Health and Swiss Country Affairs, with programs addressing malaria, neglected tropical diseases and non-communicable conditions. He also oversees the company’s presence in sub-Saharan Africa and supports public-private partnerships. His external service includes PATH and the Swiss TPH Board of Governors.
M.D. — Utrecht University.
Ph.D. — Utrecht University — Molecular Pharmacology.